Hyperglycemia in the critically ill patient

AACN Advanced Critical Care

Volumn 17, Issue 1, 2006, Pages 50-55

  Gearhart, Michelle M ^a   Parbhoo, Shilpa K ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Fort Hamilton Hospital   (United States)

Author keywords

Critical illness; Hyperglycemia; Insulin resistance; Intensive insulin therapy

Indexed keywords

ADRENALIN; ANTIDIABETIC AGENT; GLUCAGON; HYDROCORTISONE; INSULIN; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL PROTOCOL; CRITICAL ILLNESS; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; INTENSIVE CARE; METABOLISM; METHODOLOGY; MORBIDITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SEPSIS; STANDARD; STRESS; SURVIVAL RATE; TREATMENT OUTCOME;

BLOOD GLUCOSE; CLINICAL PROTOCOLS; CRITICAL CARE; CRITICAL ILLNESS; EPINEPHRINE; EVIDENCE-BASED MEDICINE; GLUCAGON; HUMANS; HYDROCORTISONE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; INSULIN RESISTANCE; MORBIDITY; NOREPINEPHRINE; PITUITARY-ADRENAL SYSTEM; PRACTICE GUIDELINES; RISK FACTORS; SEPSIS; STRESS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746076785     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/00044067-200601000-00007     Document Type: Review

References (31)

1. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endo Met. 2001;15:533-551.
2. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-124.
3. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
4. Guvener M, Pasaoglu I, Demircin M, et al. Periopertaive hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2001;49(5):531-537.
5. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-1062.
6. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;58:921-924.
7. Rovlias A, Serafim K. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000;46(2):335-342.
8. Jeremitsky E, Omert LA, Dunham CM, et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005;58:47-50.
9. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Nuerol. 2001;58:1209-1212.
10. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
11. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
12. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
13. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nut Clin Pract. 1996;11:151-156.
14. Chrousos GP. The hypothalamic-pituitary adrenal axis and immune-mediated inflammation. New Eng J Med. 1995;332(20):1351-1362.
15. Khani S, Tayek JA. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (London). 2001;101(6):739-747.
16. Brillon DJ, Zheng B, Cambell RG and Matthews DE. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol Endocrinol Metab. 1995;268:E501-E513.
17. McGuinness OP, Gugiwara T, Murrell S, Bracy D, Neal D, O'Connor D, Cherrington AD. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol Endocrinol Metab. 1993;265:E314-E322.
18. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Donahue EP, Flakoll P, Cherrington AD. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am J Physiol Endocrinol Metab. 2003;284:E695-E707.
19. Watt MJ, Howlett KF, Febbraio MA, Spriet LL, Hargreaves M. Adrenaline increases skeletal muscle glycogenolysis pyruvate dehydrogenase activation and carbohdydrate oxidation during moderate exercise in humans. J Physiol. 2001;534(Pt 1):269-278.
20. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106(2):165-169.
21. Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol. 2002;9603:1638-1643.
22. Chiaisson JL, Shikama H, Chu TDW, Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest. 1981;68:706-713.
23. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993;77(6):1690-1694.
24. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43-52.
25. Del Aguila LF, Claffey KP, Kirwan JP. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cell. Am J Physiol Endocrinol Metab. 1999;276:E849-E855.
26. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev. 1995;16(2):117-142.
27. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000.
28. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Burghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082-1088.
29. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.
30. Wall RJ, Dittus RS, Ely EW. Protocol-driven care in the intensive care unit: a tool for quality. Crit Care. 2001;5:283-285.
31. Mehta RL, Chertow G. In critically ill patients with acute renal failure outcomes, not dollars, should drive modality choice. Crit Care Med. 2003;31:644-646.